PMID: 12695346Apr 16, 2003Paper

Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro

Drug Metabolism and Disposition : the Biological Fate of Chemicals
Yoichi NaritomiYuichi Sugiyama


We investigated hepatic in vitro intrinsic clearance (CL(int,in vitro)) in freshly isolated or cryopreserved hepatocytes and compared with CL(int,in vivo) by using nine model compounds, FK1052, FK480, diazepam, diltiazem, troglitazone, quinotolast, FK079, zidovudine, and acetaminophen, in rats and humans. The compounds showed a broad range of in vivo hepatic extraction ratios (rat, 0.05-0.93; humans, 0.03-0.76) and were metabolized by hepatic P450, UDP-glucuronosyltransferase, sulfotransferase, and/or esterase. CL(int,in vitro) was determined from substrate disappearance rate at 1 microM in hepatocytes. CL(int,in vivo) was calculated from in vivo pharmacokinetic data using two frequently used mathematical models (the well stirred and dispersion models). When estimating rat CL(int,in vitro) in freshly isolated hepatocytes, the rat scaling factor values (CL(int,in vivo)/CL(int,in vitro)) showed marked difference among the model compounds (0.2-73.1-fold). The rat CL(int,in vitro) values in freshly isolated hepatocytes were in good agreement with these in cryopreserved hepatocytes. Human CL(int,in vitro) were determined by use of cryopreserved hepatocytes. When human CL(int,in vitro) was regarded as the predicted CL(int,in vivo), t...Continue Reading


Aug 1, 1992·Journal of Pharmaceutical Sciences·J M Díaz-GarcíaD Fos-Galve
Jul 1, 1989·Clinical Pharmacokinetics·J M Collins, J D Unadkat
Jan 1, 1988·European Journal of Clinical Pharmacology·J SonneK Lundstrøm
Dec 1, 1973·The Journal of Pharmacy and Pharmacology·B G GazzardR Williams
Feb 18, 1982·The American Journal of Cardiology·R W PiephoR K Browne
Oct 1, 1994·European Journal of Drug Metabolism and Pharmacokinetics·B C TsuiP K Yeung
May 1, 1994·Biopharmaceutics & Drug Disposition·B A Hoener
Dec 1, 1993·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J A CoundourisG M Hawksworth
Jul 1, 1993·Pharmaceutical Research·B Davies, T Morris
Feb 1, 1996·Pharmacology & Toxicology·H LuurilaP J Neuvonen
May 1, 1996·Biopharmaceutics & Drug Disposition·T IwatsuboY Sugiyama
Jan 1, 1997·Pharmacology & Therapeutics·T IwatsuboY Sugiyama
Jan 9, 1998·Drug Metabolism Reviews·J B Houston, D J Carlile
Dec 16, 1998·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·N J Swales, D Utesch
Apr 29, 1999·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M K BaylissK Wilson
Jul 27, 1999·Chemico-biological Interactions·A GuillouzoC Guyomard

❮ Previous
Next ❯


Nov 26, 2009·Journal of Pharmacokinetics and Pharmacodynamics·Agnès PoirierThierry Lavé
Nov 26, 2010·Journal of Pharmacokinetics and Pharmacodynamics·Michael S Roberts
Mar 3, 2007·Pharmaceutical Research·Lilian G YengiJohn Kao
Feb 3, 2009·Pharmaceutical Research·Helen E CubittAleksandra Galetin
Apr 1, 2004·Drug Discovery Today·Nick Plant
May 23, 2013·Journal of Chemical Information and Modeling·Laura GoracciGabriele Cruciani
Jul 6, 2013·Lab on a Chip·John P WikswoWilliam J Matloff
Apr 19, 2007·Clinical and Experimental Pharmacology & Physiology·Yu GuoChun Zhang
Mar 13, 2009·The AAPS Journal·Hannah M JonesKenny J Watson
Jan 27, 2012·Drug Metabolism and Pharmacokinetics·Koji ChibaYuichi Sugiyama
Sep 18, 2013·Drug Metabolism and Pharmacokinetics·Yoshihiro ShibataMasato Chiba
May 30, 2009·Environmental Health Perspectives·Richard JudsonEdwin Smith
Aug 15, 2014·The Journal of Pharmacy and Pharmacology·Ikuo YamamiyaKen-ichiro Yoshida
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Keith W Ward
Jan 16, 2010·Expert Opinion on Drug Metabolism & Toxicology·Piyun ChaoK C Cheng
Jul 16, 2008·Expert Opinion on Drug Metabolism & Toxicology·María José Gómez-LechónMaría Teresa Donato
Jan 8, 2014·Expert Opinion on Drug Metabolism & Toxicology·Li Di
Dec 18, 2013·Journal of Pharmaceutical Sciences·Regis BaudoinEric Leclerc
Jul 24, 2015·Journal of Pharmaceutical Sciences·Tom De BruynPieter P Annaert
Apr 2, 2005·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·E FlobyA K Sohlenius-Sternbeck
Aug 16, 2014·BMC Systems Biology·Brenden K PetersenC Anthony Hunt
Jul 23, 2009·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·E FlobyA-K Sohlenius-Sternbeck
Jul 14, 2010·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A-K Sohlenius-SternbeckC Petersson
Nov 17, 2011·Toxicology and Applied Pharmacology·Chong ShenGuoliang Zhang
Jan 9, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Paulo PaixãoJosé A G Morais
Apr 1, 2008·Pharmacology & Therapeutics·John C Lipscomb, Torka S Poet
Jun 15, 2007·Journal of Pharmacological and Toxicological Methods·Facundo M BerteraChristian Höcht

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.